Clinical Trials
2 trialsNCT03423264 2024-07-31
PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing
University of Chicago
Phase 2 Withdrawn
NCT03269344 2022-01-26
Gabapentin for the Reduction of Radiation Therapy Induced Pain During the Treatment of Oropharyngeal Cancer
Henry Ford Health System
Phase 3 Completed